Literature DB >> 12460197

Three T-cell determinants of Cry j 1 and Cry j 2, the major Japanese cedar pollen antigens, retain their immunogenicity and tolerogenicity in a linked peptide.

Tomomi Yoshitomi1, Kazuki Hirahara, Junko Kawaguchi, Nobufusa Serizawa, Yoshifumi Taniguchi, Saburo Saito, Masahiro Sakaguchi, Sakae Inouye, Akio Shiraishi.   

Abstract

It has been demonstrated in detail that administration of a dominant T-cell determinant to animals induces activation or immunological tolerance of T cells. However, it has not been determined whether multiple T-cell determinants, when integrated into a single peptide, retain their potential to induce T-cell activation and tolerance. We prepared a synthetic peptide comprising three T-cell determinants of Cry j 1 and Cry j 2, the major Japanese cedar pollen antigens, and investigated the immunogenicity and tolerogenicity of each T-cell determinant in the linked peptide by means of lymph node cell proliferation assays using mice. Lymph node cells from mice immunized with each of the three T-cell determinants proliferated against the linked peptide in a dose-dependent manner, similar to that of the immunized peptide. Lymph node cells from mice immunized with the linked peptide proliferated against all of the three T-cell determinants. In addition, the degree of proliferation against the three T-cell determinants occurred according to their original immunogenicity, as observed in the native protein antigens. Oral administration of the linked peptide to mice before they were immunized with Cry j 1 and Cry j 2 inhibited lymph node cell proliferation against the three T-cell determinants, depending on the dose of the linked peptide administered. In conclusion, it was demonstrated that three T-cell determinants retain their original immunogenicity and tolerogenicity in a linked peptide comprising them.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12460197      PMCID: PMC1782819          DOI: 10.1046/j.1365-2567.2002.01534.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  16 in total

1.  Immunodominance: intramolecular competition between T cell epitopes.

Authors:  D L Perkins; G Berriz; T Kamradt; J A Smith; M L Gefter
Journal:  J Immunol       Date:  1991-04-01       Impact factor: 5.422

2.  Sequence analysis of peptides bound to MHC class II molecules.

Authors:  A Rudensky; P Preston-Hurlburt; S C Hong; A Barlow; C A Janeway
Journal:  Nature       Date:  1991-10-17       Impact factor: 49.962

3.  Identification of the second major allergen of Japanese cedar pollen.

Authors:  M Sakaguchi; S Inouye; M Taniai; S Ando; M Usui; T Matuhasi
Journal:  Allergy       Date:  1990-05       Impact factor: 13.146

4.  Potential therapeutic recombinant proteins comprised of peptides containing recombined T cell epitopes.

Authors:  B L Rogers; J F Bond; S J Craig; A K Nault; D B Segal; J P Morgenstern; M S Chen; C B Bizinkauskas; C M Counsell; A M Lussier
Journal:  Mol Immunol       Date:  1994-09       Impact factor: 4.407

5.  Amino-terminal trimming of peptides for presentation on major histocompatibility complex class II molecules.

Authors:  C A Nelson; I Vidavsky; N J Viner; M L Gross; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

6.  Characterization of the specificity and duration of T cell tolerance to intranasally administered peptides in mice: a role for intramolecular epitope suppression.

Authors:  G F Hoyne; A G Jarnicki; W R Thomas; J R Lamb
Journal:  Int Immunol       Date:  1997-08       Impact factor: 4.823

Review 7.  Parameters affecting the immunogenicity of recombinant T cell epitopes inserted into hybrid proteins.

Authors:  R Lo-Man; C Leclerc
Journal:  Hum Immunol       Date:  1997-05       Impact factor: 2.850

8.  The comparison of several dose levels with a zero dose control.

Authors:  D A Williams
Journal:  Biometrics       Date:  1972-06       Impact factor: 2.571

9.  Isolation and partial characterization of the major allergen from Japanese cedar (Cryptomeria japonica) pollen.

Authors:  H Yasueda; Y Yui; T Shimizu; T Shida
Journal:  J Allergy Clin Immunol       Date:  1983-01       Impact factor: 10.793

10.  Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I.

Authors:  T J Briner; M C Kuo; K M Keating; B L Rogers; J L Greenstein
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

View more
  4 in total

1.  Development of a rice-based peptide vaccine for Japanese cedar and cypress pollen allergies.

Authors:  Fumio Takaiwa; Lijun Yang
Journal:  Transgenic Res       Date:  2014-03-18       Impact factor: 2.788

2.  A rice-based edible vaccine expressing multiple T cell epitopes induces oral tolerance for inhibition of Th2-mediated IgE responses.

Authors:  Hidenori Takagi; Takachika Hiroi; Lijun Yang; Yoshifumi Tada; Yoshikazu Yuki; Kaoru Takamura; Ryotaro Ishimitsu; Hideyuki Kawauchi; Hiroshi Kiyono; Fumio Takaiwa
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-08       Impact factor: 11.205

Review 3.  Next generation immunotherapy for tree pollen allergies.

Authors:  Yan Su; Eliezer Romeu-Bonilla; Teri Heiland
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

4.  Transcutaneous Peptide Immunotherapy of Japanese Cedar Pollinosis Using Solid-in-Oil Nanodispersion Technology.

Authors:  Momoko Kitaoka; Yoko Shin; Noriho Kamiya; Yoshinori Kawabe; Masamichi Kamihira; Masahiro Goto
Journal:  AAPS PharmSciTech       Date:  2015-05-19       Impact factor: 3.246

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.